{
  "docId": "019de073-8d45-7608-905c-741cc65d0847",
  "docSlug": "b16516ae093225c5834bc86ab14054bf",
  "documentTitle": "LumiraDx | Investor Presentation Deck | 55 slides",
  "authorId": "lumiradx",
  "authorName": "LumiraDx",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 55,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "Uses a visual 'before/after' style comparison with red X marks to indicate legacy/displaced systems.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-8d45-7608-905c-741cc65d0847/32",
  "deckHref": "/decks/019de073-8d45-7608-905c-741cc65d0847",
  "deckJsonHref": "/decks/019de073-8d45-7608-905c-741cc65d0847.json",
  "deckAnchorHref": "/decks/019de073-8d45-7608-905c-741cc65d0847#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "image",
      "text": "Six device icons, three with red X overlays",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a483ade-c202-4478-9446-10bb8660f369",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "18-24 MONTHS: Able to move most US and European customers 6 -> 1 Platform with US authorizations and addition of molecular respiratory, lipids, electrolytes, and cardiac content",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52e576ef-2f72-44f4-ad48-7fe1ea6bbc55",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "NEAR TERM: Able to move most European customers from 3 -> 1 Platform with INR, COVID Ag, Flu A/B, RSV, CRP and HbA1c",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89edbab7-197e-4f69-9b71-e721293150bd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.05
      },
      "kind": "title",
      "text": "Consolidate Multiple POC Instruments to a Single Lab Comparable Platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed41f20d-aa85-4612-92a3-62e92dd7485d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "1dde4626-df15-4856-8b2a-40ad97c5e7c8",
      "evidence": "paragraph/paragraph: 18-24 MONTHS: Able to move most US and European customers 6 -> 1 Platform with US authorizations and addition of molecular respiratory, lipids, electrolytes, and cardiac content",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "bb98ec98-5b94-470f-8105-d05deb9c17d9",
      "evidence": "Visual contrast between legacy devices marked with X and the consolidated platform goal.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}